The Kansas City Chiefs started the season 0-2, but have won five of their last six games. One of the biggest reasons why they got off to a slow start is because they were missing some of their best ...

No. 19 Kansas is just two days away from tipping off the 2025-26 college basketball campaign with a home matchup against Green Bay. Head coach Bill Self met with the media on Friday afternoon after ...

Former first son Hunter Biden said categorically that he genuinely did not think the laptop that became a nucleus of controversy was his when that story broke — and still doesn’t remember dropping it ...

Jon Jones was the last man to beat Tom Aspinall’s UFC 321 opponent. Saturday’s main event will mark Ciryl Gane’s third shot at becoming the promotion’s undisputed heavyweight king. After falling short ...

DEAR ERIC: I have an alcoholic neighbor with whom I am friendly. We do minor favors for each other. I am aware that he drinks and drives home from a nearby bar, which I have issues about. He drives a ...

A British MMA fighter claims he was attacked while walking on the streets of Montreal, Canada, because he didn’t speak French. UFC featherweight Arnold Allen dropped the surprising news Tuesday as he ...

In this insightful video, we delve into the key differences between ASUS and Wooting keyboards. Discover how these two leading brands stack up against each other in terms of performance, design, and ...

WASHINGTON, Oct 22 (Reuters) - U.S. Trade Representative Jamieson Greer on Wednesday said he did not see tons of foreign beef coming into the United States, days after President Donald Trump suggested ...

Briony spends some time today with the new wooting two keyboard and the Analog Mechanical switches inside it. The Wooting Two is a full sized variant of the Wooting One and still features the same ...

Rep. Scott Perry’s most likely 2026 opponent is calling on him to apologize after Perry said Democrats “hate the military” and only serve in the armed forces for political clout. Perry, the Republican ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...